Search   |   Advanced Search
Login   |   Check Out   |   View Cart0 Items

Home » About Us » News » Press Release

Press Releases
USDA/APHIS EC 1774:2002 Approval For Its Viral Antigens Production Facility - 10/12/2007

INFORMATION

For Immediate Release
October 12, 2007
Contact: 513.271.3700
Rick L. Eberly, President

MERIDIAN LIFE SCIENCE ANNOUNCES USDA/APHIS EC 1774:2002 APPROVAL FOR ITS VIRAL ANTIGENS PRODUCTION FACILITY

Meridian Life Science, Inc. (MLS), Cincinnati, Ohio, today announced that its Viral Antigens production facility, located in Memphis, TN recently received USDA/APHIS EC 1774:2002 approval. This important regulatory approval, for one of the largest viral antigen production facilities in the US, is the latest demonstration of MLS’ commitment to serving our customers and improving our quality systems. This registration by the USDA/APHIS allows MLS to continue to manufacture and purify viral antigens for export to Europe and provide seamless and reliable outsourcing of large-scale, viral antigen production for all European customers.

In business for over 24 years, the Viral Antigens brand is recognized as an industry leading manufacturer of viral proteins and critical assay reagents for major diagnostic companies. Many of these viral proteins are custom-developed antigens that are utilized in infectious disease diagnostic assays.

This approval is the latest in a long history of quality systems improvements for MLS facilities. In May of 2007, Meridian’s ascites production facility in Boca Raton, FL received USDA/APHIS EC 1774:2002 approval. Meridian’s biological reagents manufacturing and distribution facility in Saco, Maine has had EC 1774:2002 approval since October of 2004 and all MLS facilities are ISO 9001:2000 certified.

Richard L. Eberly, President, Meridian Life Science, Inc., commented, "This recent approval for our Viral Antigens manufacturing facility in Memphis highlights our complete commitment to on-going quality improvement for all MLS operations. MLS continues to prioritize the continued improvement of its quality systems so that we can consistently deliver the high quality products to our global customers."

MLS supplies critical assay reagents, antigens, antibodies, and contract biological R&D and manufacturing services to the research, diagnostic, and biopharmaceutical markets. MLS services its customers from three primary manufacturing operations in Memphis, Tennessee; Saco, Maine; and Boca Raton, Florida; and is represented by four business brands: BIODESIGN International, OEM Concepts, Viral Antigens, and Meridian Biologics.

For Additional Information Contact:

info@meridianlifescience.com or visit our website at www.meridianlifescience.com.


(end)
back
Copyright © 2010 Meridian Life Science,® Inc.